Search Within

Allison Betof Warner

  1. "Biostatistics Service"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (11)
Groups
  1. Biostatistics Service (24)
  2. Department of Medicine (24)
  3. Epidemiology and Biostatistics (24)
  4. Hematologic Malignancies, Division of (24)
  5. Melanoma and Immunotherapeutics Service (24)
  6. Solid Tumor Oncology Division (24)

More Groups

People
  1. Jedd Wolchok (18)
  2. Katherine Panageas (18)
  3. Michael Postow (18)
  4. Alexander Shoushtari (16)
  5. Margaret Callahan (15)
  6. Paul Chapman (15)

More People

Years
  1. 2024 (2)
  2. 2023 (5)
  3. 2022 (4)
  4. 2021 (5)
  5. 2020 (3)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal for ImmunoTherapy of Cancer (3)
  3. Clinical Cancer Research (2)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. Annals of Surgical Oncology (1)
  6. CNS Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Biomed Central Ltd (3)
  3. American Association for Cancer Research (2)
  4. Elsevier Inc. (2)
  5. Wiley Blackwell (2)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Responders to anti-PD1 therapy: Long-term outcomes and responses to retreatment in melanoma (mel)
    Meeting Abstract

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.; Chapman, P. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save